Abayneh Mengistu, Zeynudin Ahmed, Tamrat Rahel, Tadesse Mulualem, Tamirat Abraham
College of Medical and Health Science, Department of Medical Laboratory Sciences, Mizan-Tepi University, PO Box 260, Mizan-Aman, Ethiopia.
School of Medical Laboratory Sciences, Faculty of Health Sciences, Institute of Health, Jimma University, Jimma, Ethiopia.
One Health Outlook. 2023 Sep 11;5(1):12. doi: 10.1186/s42522-023-00088-z.
Although antimicrobial resistance (AMR) bacteria present a significant and ongoing public health challenge, its magnitude remains poorly understood, especially in many parts of the developing countries. Hence, this review was conducted to describe the current pooled prevalence of drug resistance, multidrug- resistance (MDR), and Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, Acinetobacter, and Pseudomonas species in humans, the environment, and animals or food of animal origin in Ethiopia.
PubMed, Google Scholar, and other sources were searched for relevant articles as per the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines. A critical appraisal for screening, eligibility, and inclusion in the meta-analysis was made based on the Joanna Briggs Institute's (JBI) essential appraisal tools. The meta-analysis was done on Statistical Software Package (STATA) version 17.0.
A total of 33 research articles were included in this systematic review and meta-analysis. Escherichia coli, Klebsiella species, Acinetobacter, and Pseudomonas species were the most frequently reported bacteria from two or more sources. More than 50% of Klebsiella species and 25% to 89% of Escherichia coli from two or more sources were resistant to all analysed antibiotics, except carbapenems. Fifty-five percent (55%) to 84% of Acinetobacter species and 33% to 79% of Pseudomonas species from human and environmental sources were resistant to all analyzed antibiotics. Carbapenem resistance was common in Acinetobacter and Pseudomonas species (38% to 64%) but uncommon in Enterobacteriaceae (19% to 44%). Acinetobacter species (92%), Klebsiella species (86%), and Pseudomonas species (79%) from human sources, and Proteus species (92%), and Acinetobacter species (83%), from environmental sources, were the common multidrug-resistant isolates. About 45% to 67% of E. coli, Klebsiella, Acinetobacter, and Pseudomonas species from human and environmental sources were ESBL producers.
Our review report concluded that there was a significant pooled prevalence of drug resistance, MDR, and ESBL-producing Enterobacteriaceae, Acinetobacter, and Pseudomonas species from two or more sources. Hence, our finding underlines the need for the implementation of integrated intervention approaches to address the gaps in reducing the emergence and spread of antibiotic- resistant bacteria.
尽管抗菌药物耐药性(AMR)细菌对公共卫生构成了重大且持续的挑战,但其严重程度仍知之甚少,尤其是在发展中国家的许多地区。因此,本综述旨在描述埃塞俄比亚人类、环境以及动物或动物源性食品中耐药、多重耐药(MDR)以及产超广谱β-内酰胺酶(ESBL)的肠杆菌科、不动杆菌属和假单胞菌属细菌的当前合并流行率。
按照系统评价和荟萃分析的首选报告项目(PRISMA)指南,在PubMed、谷歌学术及其他来源中检索相关文章。基于乔安娜·布里格斯研究所(JBI)的基本评价工具,对筛选、纳入标准以及纳入荟萃分析的研究进行严格评估。荟萃分析使用统计软件包(STATA)17.0版完成。
本系统评价和荟萃分析共纳入33篇研究文章。大肠杆菌、克雷伯菌属、不动杆菌属和假单胞菌属是来自两个或更多来源的最常报告的细菌。来自两个或更多来源的克雷伯菌属中超过50%以及大肠杆菌中25%至89%对除碳青霉烯类以外的所有分析抗生素耐药。来自人类和环境来源的不动杆菌属中55%至84%以及假单胞菌属中33%至79%对所有分析抗生素耐药。碳青霉烯类耐药在不动杆菌属和假单胞菌属中常见(38%至64%),但在肠杆菌科中不常见(19%至44%)。来自人类来源的不动杆菌属(92%)、克雷伯菌属(86%)和假单胞菌属(79%),以及来自环境来源的变形杆菌属(92%)和不动杆菌属(83%)是常见的多重耐药分离株。来自人类和环境来源的大肠杆菌、克雷伯菌属、不动杆菌属和假单胞菌属中约45%至67%是ESBL产生菌。
我们的综述报告得出结论,来自两个或更多来源的耐药、MDR以及产ESBL的肠杆菌科、不动杆菌属和假单胞菌属细菌存在显著的合并流行率。因此,我们的研究结果强调需要实施综合干预措施,以填补减少抗生素耐药细菌出现和传播方面的差距。